TB R O

DR. ARYO WIBOWO

 Penemuan Kasus TBC RO di Indonesia
Januari - Mei 2021
Target 2021 Terkonfirmasi RR/MDR
100%
90%
80%
70%
60% 413 971 88 2,623 1,702 1,965 353 309 380 133
121 222 604 135 86 91 635 209 184 195 470 692 1,28717,287
50% 254 678 159 186 280 192 296 57 363 386 566
40%
30%
20%
10%
67 228 20 440 245 288 41 18 74 28 15 97 33 99 157 2245
9 55 12 13 28 12 17 3 10 21 36 10 12 24 44 16 21 51
0% 1
EH LI EN U DI
Y A O BI R G M R EL G M A
BE
L
PR
I
NG UKU
T B T A R AU AR E L G RA UT R
SE
L
UT ES IA
AC BA T UL RT AL M BA TEN TI BA ALS EN L TI AR KE
LU NT NT PU BA RI B LS EN T L BA
AN GK A T J A J A J A L LT A LT
.B
A PU L A A P UL SU LT UL SU M M M
SU DON
B AK N JA KA K
KA
K KA M A M P PA S SU S SU SU
BE
N
KIJ O RO KEP LA M
IN
D G
 ALUR PENGOBATAN TBC RO

Juknis Penatalaksanaan TBC RO, 2020

PADUAN PENGOBATAN TBC RO
(INDONESIA 2020)

Pengelompokan obat berdasarkan

Guideline WHO terbaru

Komposisi Paduan Obat TBC RO di Indonesia:

Treatment Total treatment

Drugs composition (Current) Previous composition
option (2020) duration

All-oral shorter Bdq (6M) – Lfx – Cfz – HHD – Z – E – Eto / Lfx – Km – Mfx – Cfz – HHD – Z – E
9–11 months
regimen Cfz – Z - E – Eto / Mfx – Cfz – Z - E
5 effective drugs from Group
All-oral longer Starting with 5 drugs from Group A/B/C,
18–24 months A/B/C/D (WHO 2016),
regimen continue with 3-4 drugs after Bdq is stopped.
including injectable agents.
ALUR
INVESTIGASI
KONTAK Kontak
Serumah
Tanpa
Gejala TBC

Rujuk
Ke
Fasyankes

Evaluasi pemberian PP

5
TERIMA KASIH